2BBBullish & Bearish
Artiva Biotherapeutics, Inc. (ARTV) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 49 out of 100.
Artiva Biotherapeutics, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 70 | High |
| Momentum | 59 | Stable |
| Financial strength | 28 | Weak |
| Quality | 97 | Very Strong |
| Risk | 60 | Moderate |
| Founded | 2019 |
| Employees | 115 |
| 52-week range | $2.75 – $14.53 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-08 | — | -0.604 | — | $0.00 |
| 2026-11-10 | — | -0.5576 | — | $0.00 |
| 2026-08-27 | — | -0.6375 | — | $0.00 |
| 2026-05-08 | -0.95 | -0.8896 | $0.00 | $0.00 |